10-Propargyl-10-deazaaminopterin: Your Key Pharmaceutical Intermediate
In the intricate world of pharmaceutical manufacturing, the selection and procurement of chemical intermediates are critical to the success of drug development and production. Among these vital compounds is 10-Propargyl-10-deazaaminopterin, known in the pharmaceutical realm as Pralatrexate and identified by CAS number 146464-95-1. This molecule serves as a cornerstone for advanced therapies, particularly in the oncology sector, making it a high-demand product for pharmaceutical companies and research institutions.
As a leading supplier and manufacturer of fine chemicals, we recognize the strategic importance of intermediates like 10-Propargyl-10-deazaaminopterin. Its unique pharmacological properties as a potent antifolate and dihydrofolate reductase (DHFR) inhibitor make it indispensable for certain therapeutic applications, most notably in the treatment of specific types of lymphoma.
The Crucial Role of 10-Propargyl-10-deazaaminopterin:
10-Propargyl-10-deazaaminopterin is not just another chemical compound; it is a key building block in the creation of life-saving medications. Its efficacy stems from its ability to interfere with folate metabolism, a fundamental process for cell division and growth. By inhibiting DHFR, Pralatrexate effectively chokes off the supply of essential nucleotides required by rapidly dividing cells, such as cancer cells.
- Targeted Therapy: Its specific mechanism of action allows for targeted disruption of cancer cell machinery, minimizing damage to healthy tissues when formulated correctly.
- Research and Development: For R&D scientists, access to high-purity 10-Propargyl-10-deazaaminopterin is essential for preclinical studies, mechanism of action investigations, and the development of next-generation antifolate drugs.
- API Synthesis: It is directly used in the synthesis of the Pralatrexate API, a drug approved for specific hematological malignancies. This makes its availability from reliable manufacturers critical for commercial drug production.
Sourcing Best Practices for Procurement Managers:
When looking to buy 10-Propargyl-10-deazaaminopterin, procurement professionals should prioritize:
- Supplier Verification: Partner with manufacturers that provide comprehensive documentation, including Certificates of Analysis (CoA), and adhere to Good Manufacturing Practices (GMP) or equivalent quality standards.
- Purity and Consistency: Ensure the material consistently meets specified purity levels (e.g., ≥98%). Batch-to-batch consistency is vital for reproducible drug formulation and efficacy.
- Supply Chain Reliability: Establish relationships with suppliers who have a proven track record of stable production and timely delivery. Understanding their capacity and logistics is key.
- Competitive Pricing: Obtain multiple quotes to compare pricing for bulk purchases and understand the value proposition offered by different suppliers, factoring in quality and reliability.
As a dedicated supplier of 10-Propargyl-10-deazaaminopterin, we offer both research-grade and bulk quantities, backed by rigorous quality assurance and a commitment to customer service. Engaging with our team allows you to secure a dependable source for this critical pharmaceutical intermediate, facilitating your ongoing pharmaceutical development and manufacturing efforts.
Perspectives & Insights
Chem Catalyst Pro
“Its unique pharmacological properties as a potent antifolate and dihydrofolate reductase (DHFR) inhibitor make it indispensable for certain therapeutic applications, most notably in the treatment of specific types of lymphoma.”
Agile Thinker 7
“The Crucial Role of 10-Propargyl-10-deazaaminopterin: 10-Propargyl-10-deazaaminopterin is not just another chemical compound; it is a key building block in the creation of life-saving medications.”
Logic Spark 24
“Its efficacy stems from its ability to interfere with folate metabolism, a fundamental process for cell division and growth.”